<DOC>
	<DOCNO>NCT00467428</DOCNO>
	<brief_summary>The purpose study investigate NS2359 effective treatment ADHD adult patient .</brief_summary>
	<brief_title>Efficacy Safety NS2359 Adults With Attention Deficit Hyperactivity Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<criteria>Patients diagnosis Attention Deficit Hyperactivity Disorder ( ADHD ) , DSMIV , manifest clinical evaluation confirm structure interview use KSADSE adult ADHD module Patients CGI Global Severity ( GS ) score â‰¥4 ( moderate impairment ) The Patient provide write informed consent . Nonlactating woman childbearing potential used adequate contraception ( i.e . use oral contraceptive practise doublebarrier form birth control ) negative pregnancy test screening . Women childbearing potential postmenopausal le 2 year must negative pregnancy test screening . Any clinically unstable medical condition Clinically significant abnormal baseline laboratory value Mental retardation Organic brain disorder Nonfebrile seizure disorder Patients history eat disorder include anorexia bulimia nervosa Psychotic disorder type Patients HAMD ( 17 item ) &gt; 15 Patients currently ( within past 6 month ) know abuse dependent drug , include alcohol positive urine drug screen cocaine , heroin , marijuana Treatment stimulant prohibit within 1 week prior randomisation Treatment antipsychotics/neuroleptics prohibit 8 week prior randomisation Treatment monoamine oxidase inhibitor prohibit 8 week prior randomisation Treatment tricyclic antidepressant , histamine selective serotonin reuptake inhibitor prohibit 4 week ( fluoxetine 6 week ) prior randomisation Treatment benzodiazepine , anticonvulsant ( behaviour ) lithium 2 week prior randomisation Patients history bipolar disorder Patients use concurrent medication treatment ADHD Patients previously participate NS2359 study Patients treat investigational drug within 30 day 5 halflives ( whichever longer ) precede first dose study medication Patients history positive human immunodeficiency virus ( HIV ) test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>ADHD</keyword>
</DOC>